BIOLOGICAL AND THERAPEUTIC SIGNIFICANCE OF C-MET PATHWAY IN OVARIAN CANCER

被引：0
|
作者：
Wang, K. L. [1 ]
Wu, C. C. [2 ]
Hsu, Y. T. [2 ]
Chang, C. L. [3 ]
机构：
[1] Taitung MacKay Mem Hosp, Dept Obstet & Gynecol, Taitung, Taiwan
[2] MacKay Mem Hosp, Dept Med Res, New Taipei, Taiwan
[3] MacKay Mem Hosp, Dept Obstet & Gynecol, Taipei, Taiwan
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2016年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IGCS-0159
引用
收藏
页码：655 / 655
页数：1
相关论文
共 50 条
  • [41] c-Met Is a Marker of Pancreatic Cancer Stem Cells and Therapeutic Target
    Li, Chenwei
    Wu, Jing-Jiang
    Hynes, Mark
    Dosch, Joseph
    Sarkar, Bedabrata
    Welling, Theodore H.
    di Magliano, Marina Pasca
    Simeone, Diane M.
    GASTROENTEROLOGY, 2011, 141 (06) : 2218 - U395
  • [42] Prognostic Significance of c-Met Expression in Glioblastomas
    Kong, Doo-Sik
    Song, Sang-Yong
    Kim, Duk-Hwan
    Joo, Kyeung Min
    Yoo, Jin-San
    Koh, Jong Sung
    Dong, Seung Myung
    Suh, Yeon-Lim
    Lee, Jung-Il
    Park, Kwan
    Kim, Jong Hyun
    Nam, Do-Hyun
    CANCER, 2009, 115 (01) : 140 - 148
  • [43] C-met as a therapeutic target for metastatic potential of gastric cancer.
    Cho, H.
    Zhang, X.
    Jung, M.
    Kwon, W.
    Jung, J.
    Jeung, H.
    Roh, J. K.
    Chung, H. C.
    Rha, S. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [44] Current advances of targeting HGF/c-Met pathway in gastric cancer
    Anestis, Aristomenis
    Zoi, Ilianna
    Karamouzis, Michalis V.
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (12)
  • [45] Targeting the HGF/c-MET pathway: stromal remodelling in pancreatic cancer
    Pothula, Srinivasa P.
    Xu, Zhihong
    Goldstein, David
    Merrett, Neil
    Pirola, Romano C.
    Wilson, Jeremy S.
    Apte, Minoti V.
    ONCOTARGET, 2017, 8 (44) : 76722 - 76739
  • [46] Tumour angiogenesis and c-Met pathway activation - implications in breast cancer
    Mitra, Suvradeep
    Bal, Amanjit
    Kashyap, Dharambir
    Kumar, Sandeep
    Shrivastav, Shreya
    Das, Ashim
    Singh, Gurpreet
    APMIS, 2020, 128 (04) : 316 - 325
  • [47] Developing c-MET pathway inhibitors for cancer therapy: progress and challenges
    Liu, Xiangdong
    Newton, Robert C.
    Scherle, Peggy A.
    TRENDS IN MOLECULAR MEDICINE, 2010, 16 (01) : 37 - 45
  • [48] Stromal reprogramming offers a novel therapeutic approach in pancreatic cancer: Implications of targeting HGF/c-MET pathway
    Pothula, S.
    Xu, Z.
    Goldstein, D.
    Pirola, R.
    Wilson, J.
    Apte, M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 62 - 62
  • [49] Antibody targeting of the HGF/c-Met pathway
    Bottaro, D. P.
    ANNALS OF ONCOLOGY, 2008, 19 : 22 - 22
  • [50] Involvement of c-Met/hepatocyte growth factor pathway in cholangiocarcinoma cell invasion and its therapeutic inhibition with small interfering RNA specific for c-Met
    Leelawat, Kawin
    Leelawat, Surang
    Tepaksorn, Panada
    Rattanasinganchan, Panthip
    Leungchaweng, Anicha
    Tohtong, Rutaiwan
    Sobhon, Prasert
    JOURNAL OF SURGICAL RESEARCH, 2006, 136 (01) : 78 - 84
12345